Shuyu F. Zhang

516 Jun Gong Road
Shanghai, 200093, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 175 publications

pH-regulated ''ON/OFF'' glucose oxidase nanoparticles for synergistic therapy and amplification of immunogenic cell death.

pH-regulated ''ON/OFF'' glucose oxidase nanoparticles for synergistic therapy and amplification of immunogenic cell death.

Journal: Free radical biology & medicine

Published: April 02, 2026

Spatiotemporally controlled depletion of efflux-dominant cells enhances intratumoral delivery of nanomedicines.

Spatiotemporally controlled depletion of efflux-dominant cells enhances intratumoral delivery of nanomedicines.

Journal: Nanomedicine : nanotechnology, biology, and medicine

Published: March 26, 2026

Development and Application of Radiation-Induced Skin Injury Animal Models Based on Strontium-90 β-rays.

Development and Application of Radiation-Induced Skin Injury Animal Models Based on Strontium-90 β-rays.

Journal: Journal of visualized experiments : JoVE

Published: February 16, 2026

Dose Reconstruction After a WD‒XRF Spectrometer Accident Using Minute-Rate TLD Measurements.

Dose Reconstruction After a WD‒XRF Spectrometer Accident Using Minute-Rate TLD Measurements.

Journal: Dose-response : a publication of International Hormesis Society

Published: February 05, 2026

ROMO1 Promotes the Repair of Radiation-induced Skin Injury by Regulating Mitochondrial Function and Keratinocyte Proliferation

ROMO1 Promotes the Repair of Radiation-induced Skin Injury by Regulating Mitochondrial Function and Keratinocyte Proliferation

Journal: Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition

Published: October 12, 2025

A dual-responsive metal-polyphenol nanomedicine based on targeting LAT1 via levodopa and ROS amplification for precise treatment of breast cancer.

A dual-responsive metal-polyphenol nanomedicine based on targeting LAT1 via levodopa and ROS amplification for precise treatment of breast cancer.

Journal: Free radical biology & medicine

Published: September 05, 2025

Role and Potential Mechanisms of Peroxisome Proliferator-Activated Receptor α in Ultraviolet B Radiation-Induced Skin Damage

Role and Potential Mechanisms of Peroxisome Proliferator-Activated Receptor α in Ultraviolet B Radiation-Induced Skin Damage

Journal: Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition

Published: August 12, 2025

Single-cell RNA sequencing-guided drug discovery to alleviate radiotherapy-induced esophageal toxicity.

Single-cell RNA sequencing-guided drug discovery to alleviate radiotherapy-induced esophageal toxicity.

Journal: Acta pharmaceutica Sinica. B

Published: July 29, 2025

Author Correction: Tetrahydrobiopterin metabolism attenuates ROS generation and radiosensitivity through LDHA S-nitrosylation: novel insight into radiogenic lung injury.

Author Correction: Tetrahydrobiopterin metabolism attenuates ROS generation and radiosensitivity through LDHA S-nitrosylation: novel insight into radiogenic lung injury.

Journal: Experimental & molecular medicine

Published: July 14, 2025

miR-338-3p promotes radiation recall like dermatitis by suppressing pleiotrophin via the PI3K/Akt/Bcl2 pathway.

miR-338-3p promotes radiation recall like dermatitis by suppressing pleiotrophin via the PI3K/Akt/Bcl2 pathway.

Journal: Molecular biomedicine

Published: June 19, 2025

Dual Interfacial Engineering of Cracked NiCoP Electrode with Directed Bubbling for Efficient and Stable Hydrogen Evolution.

Dual Interfacial Engineering of Cracked NiCoP Electrode with Directed Bubbling for Efficient and Stable Hydrogen Evolution.

Journal: Small (Weinheim an der Bergstrasse, Germany)

Published: May 20, 2025

How histone modifications influence cellular radiosensitivity: Pharmaceutically targeting epigenetic regulators as a promising avenue to overcome radioresistance.

How histone modifications influence cellular radiosensitivity: Pharmaceutically targeting epigenetic regulators as a promising avenue to overcome radioresistance.

Journal: Acta pharmaceutica Sinica. B

Published: May 15, 2025

Showing 1-12 of 175

Last Updated: 09/26/2026